• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID:201901007826407964   Update date: Jan. 13, 2025

Higuchi Takashi

ヒグチ タカシ | Higuchi Takashi
Clips
Affiliation and department:
Job title: 部長
Other affiliations (1):
  • Kanazawa University
Research field  (1): Orthopedics
Research keywords  (4): 肉腫 ,  腫瘍学 ,  整形外科 ,  骨軟部腫瘍
Research theme for competitive and other funds  (6):
  • 2020 - 2022 マルチキナーゼ阻害薬による新規骨肉腫治療の開発
  • 2021 - 2022 Clinical and pathological analysis of factors affecting chemoresistance in osteosarcoma patients
  • 2021 - 2022 Analysis of effects of multikinase inhibitors on osteosarcoma
  • 2019 - 2019 肉腫の転移浸潤メカニズムの解明と新規治療の開発
  • 2017 - 2018 Graduate-Level Research Exchange
Show all
Papers (155):
  • Sei Morinaga, Ming Zhao, Kohei Mizuta, Byung Mo Kang, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, et al. The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo. In vivo (Athens, Greece). 2025. 39. 1. 102-109
  • Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung Mo Kang, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, et al. Synergistic Eradication of Fibrosarcoma With Acquired Ifosfamide Resistance Using Methionine Restriction Combined With Ifosfamide in Nude-mouse Models. In vivo (Athens, Greece). 2025. 39. 1. 120-126
  • Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung Mo Kang, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, et al. Ivermectin Combined With Recombinant Methioninase (rMETase) Synergistically Eradicates MiaPaCa-2 Pancreatic Cancer Cells. Anticancer research. 2025. 45. 1. 97-103
  • Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung Mo Kang, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, et al. Selective Synergy of Recombinant Methioninase Plus Docetaxel Against Docetaxel-resistant and -sensitive Fibrosarcoma Cells Compared to Normal Fibroblasts. Anticancer research. 2024. 44. 12. 5207-5213
  • Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung M Kang, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, et al. Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells. Anticancer research. 2024. 44. 11. 4773-4778
more...
MISC (189):
  • 五十嵐 健太郎, 山本 憲男, 樋口 貴史, ロバート・ホフマン, 土屋 弘行. 【軟部肉腫の治療update】マウスモデルを用いた軟部肉腫に対する新規治療薬開発. 整形・災害外科. 2022. 65. 3. 311-319
  • 荒木 麗博, 山本 憲男, 林 克洋, 武内 章彦, 三輪 真嗣, 五十嵐 健太郎, 樋口 貴史, 米澤 宏隆, 森永 整, 淺野 陽平, et al. 悪性骨腫瘍切除後の再建に使用した液体窒素処理自家骨の骨シンチによるviability評価. 日本整形外科学会雑誌. 2022. 96. 2. S293-S293
  • 荒木 麗博, 山本 憲男, 前田 亨, 木村 浩明, 樋口 貴史, 土屋 弘行. 2-5cmサイズの軟部腫瘍への対応の検討. 日本癌治療学会学術集会抄録集. 2021. 59回. O82-1
  • Takashi Higuchi, Kentaro Igarashi, Hiromichi Oshiro, Kentaro Miyake, Norihiko Sugisawa, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Zhenfeng Duan, et al. Patient-derived orthotopic xenograft models for osteosarcoma individualized precision treatment and effective drug discovery. Annals of Joint. 2021. 6
  • 荒木 麗博, 山本 憲男, 林 克洋, 武内 章彦, 三輪 真嗣, 五十嵐 健太郎, 樋口 貴史, 米澤 宏隆, 森永 整, 淺野 陽平, et al. 75歳以上の原発性骨肉腫8例について. 日本整形外科学会雑誌. 2021. 95. 6. S1428-S1428
more...
Lectures and oral presentations  (91):
  • 大腿軟部腫瘤の一例
    (第17回金沢骨軟部腫瘍セミナー 2024)
  • 基幹病院勤務医におけるジクトルテープ75mgの使用経験~なぜ、整形外科医こそジクトルテープなのか~
    (ジクトルテープ75mg発売3周年記念講演会in石川県 2024)
  • PPAR gamma agonist overcomes doxorubicin-resistance by modulating P-glycopr otein
    (2024)
  • Osteosarcoma patient-derived orthotopic xenograft identifying novel and effective therapies: A review
    (22nd International Society of Limb Salvage General Meeting 2024 2024)
  • Long-term survival after metasectomy in patients with bone or soft-tissuemetastases from renal cell carcinoma.
    (ASCO Breakthrough 2024)
more...
Education (2):
  • - 2018 Kanazawa University Graduate School of Medical Science
  • - 2009 Kanazawa University
Professional career (1):
  • 医学博士 (金沢大学大学院医薬保健学総合研究科)
Work history (9):
  • 2022/04 - 現在 Kanazawa Red Cross Hospital Orthopaedic Surgery Manager
  • 2020/04 - 2022/03 Japanese Red Cross Kanazawa Hospital Orahopaedic Surgery vice manager
  • 2020/01 - 2020/03 Kanazawa University Hospital Department of Orthopaedic Surgery Medical staff
  • 2017/11 - 2019/12 University of California San Diego (UCSD) Department of Surgery Visiting scholar
  • 2013/10 - 2017/10 金沢大学付属病院 整形外科 医員
Show all
Awards (4):
  • 2021/06 - Kanazawa University Juzen Medical Society 1st Juzen Medical Encouragement Award Mechanism of metastasis and new treatment development in sarcoma
  • 2018/10 - 39th Société Internationale de Chirurgie Orthopédique et de Traumatologie(SICOT)Orthopaedic World Congress The Lester Lowe SICOT Award
  • 2018/09 - Kanazawa University President Award Anti-tumor effects of a non-steroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression
  • 2017/10 - Society Encouragement Award
Association Membership(s) (5):
International Society Of Limb Salvage ,  Société Internationale de Chirurgie Orthopédique et de Traumatologie International Society of Orthopaedic Surgery and Traumatology ,  JAPAN SOCIETY OF CLINICAL ONCOLOGY ,  The Central Japan Association of Orthopaedic Surgery and Traumatology ,  THE JAPANESE ORTHOPAEDIC ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page